...
首页> 外文期刊>Biologicals: Journal of the International Association of Biological Standardization >Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).
【24h】

Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).

机译:开发用于评估眼镜蛇抗蛇毒血清(ASVS)效能的被动血凝(PHA)和血凝抑制(HAI)技术。

获取原文
获取原文并翻译 | 示例
           

摘要

Antibodies against snake venom or antivenom potency are assayed quantitatively by in-vivo neutralization test in mice, which requires large number of laboratory animals. In potency assays of biological substances such as antivenoms, it is highly desirable to avoid suffering and death of animals by substituting in-vivo method with in-vitro methods, provided such methods measure life-saving capability with precision similar to that of in-vivo method. The in-vitro tests determine the neutralizing power of antivenom by permitting the evaluation of a particular biological activity of the venom and its neutralization after mixing the venom with the antivenom [Theakston RDG, Reid HA. Development of simple standard assay procedures for the characterization of snake venom. Bull WHO 1983;61:949-956; Gutierrez JM, Rojas G, Lomonte B, Gene JA, Chaves F, Alvarado J, et al. Standardizing of assays for testing the neutralizing ability of antivenoms. Toxicon 1990;28:1127-1129; Theakston R.D.G. Comments on letter of Gutierrez et al. on standardization of assays for testing the neutralizing ability of antivenoms. Toxicon 1990;28:1131-1132; Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB. Screening of snake venom for neurotoxic and myotoxic effects using simple in-vitro preparation from rodents and chicks. Toxicon 1994;32:257-265; World Health Organization Progress in characterization of venom and standardization of anti-venoms. Geneva: WHO offset publication; 1981. p. 58.]. Hence, the ideal requirements for an assay in detecting venom and venom antibody include high level of sensitivity, specificity (ability to differentiate between venom and venom antibody produced by closely related species of snakes), reproducibility and simplicity. A new in-vitro procedure for quantitative analysis of potency of ASVS by passive haemagglutination (PHA) and haemagglutination inhibition (HAI) has been explored. The methods described are simple, rapid, economical, reproducible and useful in replacing the more expensive in-vivo neutralization assays. Moreover, it also eliminates the use of laboratory animals.
机译:通过体内中和试验在小鼠中定量测定抗蛇毒或抗蛇毒的抗体,这需要大量的实验动物。在生物物质(如抗蛇毒血清)的效价测定中,非常希望通过用体内方法代替体外方法来避免动物的痛苦和死亡,只要这种方法能够以与体内相似的精度测量救生能力方法。体外试验通过允许评估毒液的特定生物活性以及将毒液与抗毒液混合后的中和作用来确定抗毒液的中和能力[Theakston RDG,Reid HA。开发用于蛇毒表征的简单标准测定程序。 Bull WHO 1983; 61:949-956; Gutierrez JM,Rojas G,Lomonte B,Gene JA,Chaves F,Alvarado J等。用于测试抗蛇毒的中和能力的分析方法的标准化。 Toxicon 1990; 28:1127-1129; Theakston R.D.G.评论古铁雷斯等人。检测抗蛇毒的中和能力的标准化方法的研究。 Toxicon 1990; 28:1131-1132;哈维(Harvey),巴尔法拉(Barfaraz),汤姆森(E),法伊斯(Faiz),普雷斯顿(Preston),哈里斯(Harris)JB。使用简单的体外啮齿动物和雏鸡制备方法,对蛇毒的神经毒性和肌毒性作用进行筛选。 Toxicon 1994; 32:257-265;世界卫生组织在毒液定性和反毒液标准化方面取得进展。日内瓦:世卫组织抵消出版物; 1981年。 58.]。因此,检测蛇毒和蛇毒抗体的理想方法包括高水平的灵敏度,特异性(区分蛇类和紧密相关蛇毒产生的蛇毒抗体的能力),再现性和简便性。探索了一种新的体外程序,用于通过被动血凝(PHA)和血凝抑制(HAI)定量分析ASVS的效力。所描述的方法简单,快速,经济,可重现,可用于替代更昂贵的体内中和测定。此外,它也消除了对实验动物的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号